Patents by Inventor Zhiliang Ma

Zhiliang Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250098452
    Abstract: Display substrate, method for manufacturing the same, and display device are disclosed. The display substrate comprises: a base substrate comprising a display region and a peripheral region located at a periphery of the display region, the display region comprises at least two display sub-regions; the display substrate further comprises scanning lines and sub-pixels, wherein the scanning lines comprise first scanning lines comprising at least two scanning line segments independent from each other, and the at least two scanning line segments are located in different display sub-regions; and the sub-pixels are divided into rows of sub-pixels, the rows of sub-pixels comprise a target row of sub-pixels which is divided into at least two sub-pixel groups located in different display sub-regions, and the scanning line segment is coupled to each sub-pixel in a corresponding sub-pixel group belonging to a same display sub-region.
    Type: Application
    Filed: February 22, 2023
    Publication date: March 20, 2025
    Applicants: CHENGDU BOE OPTOELECTRONICS TECHNOLOGY CO., LTD., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Ziyang YU, Ming HU, Zhiliang JIANG, Haijun QIU, Long MA, Tianyi CHENG, Jianpeng WU, Qingqing YAN, Xiangnan PAN, Quanyong GU, Pan ZHAO, Qing HE
  • Patent number: 12214091
    Abstract: The present invention relates to a sodium polyacrylate super absorbent resin for blood absorption with a gradual hierarchical structure. When a blood simulant solution is used as the detection medium, according to ISO 19699-1:2017(E), the absorption capacity of the blood simulant solution is ?18.0 g/g, Preferably ?18.5 g/g; the absorption rate of the blood simulant solution is ?45 s, preferably ?40 s, more preferably ?38 s; when human blood is used as the detection medium, according to ISO 19699-1:2017(E), the absorption capacity of the human blood is ?8.0 g/g, preferably ?8.3 g/g, more preferably ?8.6 g/g; the absorption rate of the human blood is ?45 s, preferably ?40 s, more preferably ?35 s, most preferably ?25 s.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: February 4, 2025
    Assignee: SHANDONG HAOYUE NEW MATERIALS CO., LTD
    Inventors: Zhiliang Yang, Hao Yang, Yanyu Ma, Yang Yang, Xiang Zhang, Meiqin Yao, Jinshui Yao
  • Patent number: 10949771
    Abstract: Systems, methods, and non-transitory computer-readable media can collect past user information and churn data for a plurality of users. A churn prediction model is trained using the past user information and churn data. A churn propensity score is calculated for a present user based on the churn prediction model, the churn propensity score indicative of the likelihood of the present user to churn.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: March 16, 2021
    Assignee: Facebook, Inc.
    Inventors: Vincent Gonguet, Aude Hofleitner, Sofus Attila Macskassy, Steven James Jarrett, Aruna Bharathi, Zhiliang Ma
  • Publication number: 20170220933
    Abstract: Systems, methods, and non-transitory computer-readable media can collect past user information and churn data for a plurality of users. A churn prediction model is trained using the past user information and churn data. A churn propensity score is calculated for a present user based on the churn prediction model, the churn propensity score indicative of the likelihood of the present user to churn.
    Type: Application
    Filed: January 28, 2016
    Publication date: August 3, 2017
    Inventors: Vincent Gonguet, Aude Hofleitner, Sofus Attila Macskassy, Steven James Jarrett, Aruna Bharathi, Zhiliang Ma